Compare BioNano Genomics Inc (BNGO) vs IAC/Interactivecorp (PPLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs IAC/Interactivecorp — how do they compare? BioNano Genomics Inc trades at $1.24 (market cap $13.66M), while IAC/Interactivecorp trades at $40.21 (market cap $2.97B). The key difference: IAC/Interactivecorp is far larger — about 217.4× BioNano Genomics Inc's market cap, and IAC/Interactivecorp is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | PPLI | |
|---|---|---|
Market Cap | $13.66M | $2.97B |
Sector | Health | Media |
52-Week High | $4.92 | $47.62 |
52-Week Low | $1.06 | $31.52 |
Enterprise Value | $16.26M | $3.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
PPLI trades at $40.60, down 0.15% on the day, with a bearish technical signal. Recent Q2 2026 earnings beat expectations at $6.77 EPS, driven by digital growth and MGM investment gains. The company shows strong profitability margins but volatile cash flows, with a net cash outflow of $820.42 million in 2025. Valuation ratios appear attractive with a P/E of 6.76 and P/B of 0.59.
Outlook is mixed: analyst consensus is bullish with a $60.50 price target, but risks include inconsistent earnings, high debt, and negative operating cash flow. The stock offers value potential if turnaround plans succeed, yet faces execution challenges in monetizing non-core assets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About IAC/Interactivecorp
IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →
